Article
Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine - 1 Apr 2017
Montel Aline Monezi, Dos Santos Raquel Gouvêa, da Costa Pryscila Rodrigues, Silveira-Lacerda Elisângela de Paula, Batista Alzir Azevedo, Dos Santos Wagner Gouvêa
Abstract excerpt
Novel metal complexes have received great attention in the last decades due to their potential anticancer activity. Notably, ruthenium-based complexes have emerged as good alternative to the currently used platinum-based drugs for cancer therapy, providing less toxicity and side effects to patients. Glioblastoma is an aggressive and invasive type of brain tumor and despite of advances is the field of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
